Literature DB >> 23357531

Familial hypercholesterolemia affects microvascular autoregulation in children.

Oliver Schlager1, Kurt Widhalm, Alexandra Hammer, Aura Giurgea, Christian Margeta, Maria Fritsch, Sonja Zehetmayer, Renate Koppensteiner, Michael E Gschwandtner, Andrea Willfort-Ehringer.   

Abstract

OBJECTIVE: Familial hypercholesterolemia (FH) impairs macrovascular endothelial function in childhood and causes an increase of cardiovascular risk in later life. Whether microvascular function is affected in children with FH is unknown. The aim of this study was to investigate the impact of FH on microvascular autoregulation in children by post occlusive reactive hyperemia (PORH).
METHODS: PORH of the skin was assessed using laser Doppler fluxmetry. Baseline perfusion, biological zero, defined as no-flow laser Doppler signal during suprasystolic occlusion, peak perfusion after release of suprasystolic occlusion, as well as time to peak perfusion and recovery time, defined as time until baseline perfusion is resumed, were measured in 16 children, who were diagnosed with FH according to current guidelines, and in 91 healthy controls.
RESULTS: In children with FH, peak perfusion was higher (FH: 1.60±0.68 vs. controls: 1.26±0.50 AU [arbitrary units], p=0.02), recovery time was longer (110±42.61 vs. 83.18±35.08 s, p=0.01) and biological zero was lower than in controls (0.12±0.04 vs. 0.18±0.05 AU, p<0.001). Baseline perfusion and time to peak were not different between children with FH and controls (baseline perfusion: 0.43±0.21 vs. 0.38±0.15 AU, p=0.18; time to peak: 15.44±12.25 vs. 18.18±17.79 s, p=0.56).
CONCLUSION: For the first time the present study reveals an impact of FH on microvascular autoregulation in children: the differences of PORH between children with FH and controls indicate an affected autoregulation of microvascular blood flow in FH, which has its onset in childhood.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23357531     DOI: 10.1016/j.metabol.2012.12.013

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  2 in total

1.  Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke.

Authors:  Alpo Vuorio; Markku Kaste; Petri T Kovanen
Journal:  eNeurologicalSci       Date:  2021-04-27

2.  Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia.

Authors:  Congwu Huang; Chuan Cen; ChengXu Wang; Haiyong Zhan; Xin Ding
Journal:  Lipids Health Dis       Date:  2014-04-17       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.